# A Newly Diagnosed Patient With Human Immunodeficiency Virus (HIV)-Associated Epstein-Barr Virus (EBV)-Positive Diffuse Large B-cell Lymphoma and Esophageal Candidiasis: A Case Report

## TL;DR

This case report describes an HIV patient with EBV-related lymphoma and esophageal candidiasis, emphasizing the need for awareness of HIV-related complications.

## Contribution

The case highlights the co-occurrence of EBV-positive DLBCL and esophageal candidiasis in a newly diagnosed HIV patient.

## Key findings

- The patient presented with EBV-associated diffuse large B-cell lymphoma and esophageal candidiasis.
- HIV-related complications require increased awareness and close follow-up despite HAART advancements.

## Abstract

The link between the Epstein-Barr virus (EBV) and the development of certain types of lymphomas in patients with human immunodeficiency virus (HIV) is of noteworthy clinical importance. Their immunocompromised state increases the risk of cancers such as lymphomas. Gastrointestinal (GI) lymphomas, though, can occur due to the immunosuppression caused by HIV, with diffuse large B-cell lymphoma (DLBCL) being common in this group. This case report describes a case of a patient with a newly diagnosed HIV who initially presented with symptoms associated with EBV-associated DLBCL and with esophageal candidiasis. This case report highlights the need for increased awareness of HIV-related complications and the importance of close follow-up. In addition, despite advancements in highly active antiretroviral therapy (HAART), acquired immunodeficiency syndrome (AIDS)-related lymphomas continue to be a concern requiring treatment approaches.